Comparison of the Effects of Repaglinide and Metformin on Glucose Excursions in Newly Diagnosed Type 2 Diabetes Patients in China.
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Metformin (Primary) ; Repaglinide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 26 Aug 2009 Planned end date changed from 1 Oct 2009 to 1 Dec 2009 as reported by ClinicalTrials.gov.
- 05 Feb 2009 New trial record